- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 23rd, 2008
Gold nanoparticles improve failed HIV drug's efficacy
Researchers at North Carolina State University say that lab experiments with gold nanoparticles have shown that it may be possible to resurrect a failed HIV drug called TAK779, ruled out as a useful therapy in the early Nineties due to its severe side effects, using them.
The researchers say that an ammonium salt in the drug was the main cause of harmful side effects, and that reducing it was just not possible because it would render the drug useless against HIV by disabling the resulting molecule to bind to the virus tightly.
Now, they insist, their study has shown some promise in improving the efficacy of the drug (without in binding the ammonium salt) in binding to HIV by combining it with gold nanoparticles.
|Related News Press|
News and information
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins July 26th, 2016
Accurate design of large icosahedral protein nanocages pushes bioengineering boundaries: Scientists used computational methods to build ten large, two-component, co-assembling icosahedral protein complexes the size of small virus coats July 25th, 2016
Ultrasensitive sensor using N-doped graphene July 26th, 2016